A review of emerging trends in the treatment of tuberculosis

References

• Ahmad Z, Sharma S, Khuller GK. 2005. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int J Antimicrob Agents. 26:298–303.
   PubMed Web of Science ®Google Scholar
• Barrow EL, Winchester GA, Staas JK, Quenelle DC, Barrow WW. 1998. Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages. Antimicrob Agents Chemother. 42:2682–2689.
   PubMed Web of Science ®Google Scholar
• El-Ridy MS, Mostafa DM, Shehab A, Nasr EA, Abd El-Alim S. 2007. Biological evaluation of pyrazinamide liposomes for treatment of Mycobacterium tuberculosis. Int J Pharm. 330:82–88.
   PubMed Web of Science ®Google Scholar
• Gabor F, Bogner E, Weissenboeck A, Wirth M. 2004. The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery. Adv Drug Deliv Rev. 56:459–480.
   PubMed Web of Science ®Google Scholar
• Gagandeep, Garg T, Malik B, Rath G, Goyal AK. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
   PubMed Web of Science ®Google Scholar
• Gangadharam PR, Ashtekar DA, Ghori N, Goldstein JA, Debs RJ, Duzgunes N. 1991. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J Antimicrob Chemother. 28:425–435.
   PubMed Web of Science ®Google Scholar
• Garcia-Contreras L, Fiegel J, Telko MJ, Elbert K, Hawi A, Thomas M, et al. 2007. Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model. Antimicrob Agents Chemother. 51:2830–2836.
   PubMed Web of Science ®Google Scholar
• Garg T. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. 2012. Iontophoresis: Drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett. 2:270–280.
   Google Scholar
• Garg T, Goyal AK. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. 2014b. Liposomes: Targeted and controlled delivery system. Drug Deliv Lett. 4:62–71.
   Google Scholar
• Garg T, Goyal AK, Arora S, Murthy R. 2012a. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
   Google Scholar
• Garg T, Singh O, Arora S, Murthy R. 2012b. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
   PubMed Web of Science ®Google Scholar
• Gelperina S, Kisich K, Iseman MD, Heifets L. 2005. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Respir Crit Care Med. 172:1487–1490.
   PubMed Web of Science ®Google Scholar
• Goyal AK, Rath G, Garg T. 2013a. Nanotechnological approaches for genetic immunization. DNA and RNA Nanobiotechnologies in Medicine: Diagnosis and Treatment of Diseases 67–120.
   Google Scholar
• Goyal G, Garg T, Malik B, Chauhan G, Rath G, Goyal AK. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. 2014. Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst. 31:89–119.
   PubMed Web of Science ®Google Scholar
• Johal HS, Garg T, Rath G, Goyal AK. 2014. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 1–14.
   Web of Science ®Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. 2014. Advanced drug delivery approaches against periodontitis. Drug Deliv. 1–15.
   Web of Science ®Google Scholar
• Kataria K, Sharma A, Garg T, Goyal AK, Rath G. 2014. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 4:79–86.
   Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. 2014a. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31:49–88.
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, Rath G, Goyal AK. 2014b. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Das Gupta U, Gupta P, Rath G, Goyal AK. 2014c. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Malik B, Gupta UD, Gupta P, Rath G, Goyal AK. 2014d. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. 1–6.
   Web of Science ®Google Scholar
• Klemens SP, Cynamon MH, Swenson CE, Ginsberg RS. 1990. Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob Agents Chemother. 34:967–970.
   PubMed Web of Science ®Google Scholar
• Kumar PV, Agashe H, Dutta T, Jain NK. 2007. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv. 4:11–19.
   PubMedGoogle Scholar
• Lu D, Garcia-Contreras L, Xu D, Kurtz SL, Liu J, Braunstein M, et al. 2007. Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharm Res. 24:1834–1843.
   PubMed Web of Science ®Google Scholar
• Marwah H, Garg T, Goyal AK, Rath G. 2014. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 1–15.
   Web of Science ®Google Scholar
• Pandey R, Khuller GK. 2005a. Antitubercular inhaled therapy: opportunities, progress and challenges. J Antimicrob Chemother. 55:430–435.
   PubMed Web of Science ®Google Scholar
• Pandey R, Khuller GK. 2005b. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis (Edinb). 85:227–234.
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma A, Zahoor A, Sharma S, Khuller GK, Prasad B. 2003. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. J Antimicrob Chemother. 52:981–986.
   PubMed Web of Science ®Google Scholar
• Pandey R, Sharma S, Khuller GK. 2005. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis (Edinb). 85: 415–420.
   PubMed Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, Goyal AK. 2013. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol.
   PubMed Web of Science ®Google Scholar
• Qurrat ul A, Sharma S, Khuller GK, Garg SK. 2003. Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. J Antimicrob Chemother. 51:931–938.
   PubMed Web of Science ®Google Scholar
• Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S, Markandeywar T. 2014a. Nanogel-an advanced drug delivery tool: Current and future. Artif Cells Nanomed Biotechnol. 1–13.
   Web of Science ®Google Scholar
• Sharma A, Sharma S, Khuller GK. 2004. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. J Antimicrob Chemother. 54:761–766.
   PubMed Web of Science ®Google Scholar
• Sharma R, Singh H, Joshi M, Sharma A, Garg T, Goyal AK, Rath G. 2014b. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst. 31:187–217.
   PubMed Web of Science ®Google Scholar
• Singh B, Garg T, Goyal AK, Rath G. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
   Web of Science ®Google Scholar
• Singh H, Sharma R, Joshi M, Garg T, Goyal AK, Rath G. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
   Web of Science ®Google Scholar
• Suarez S, O’Hara P, Kazantseva M, Newcomer CE, Hopfer R, Mcmurray DN, Hickey AJ. 2001. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm Res. 18:1315–1319.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. 2004. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm. 269:37–49.
   PubMed Web of Science ®Google Scholar